GL vs OGEN · P/E 10, $10.26B cap vs rev $37.7K
Globe Life Inc (GL) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Globe Life Inc (GL) is a insurance - life company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
GL does not have a complete income-statement cache yet.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
GL currently screens at market cap $10.26B and trailing P/E 10.1. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the GL and OGEN stock pages for the full models.
Not investment advice.